Expert Medical Council
CLL Society has established an Expert Medical Council which is comprised of a diverse group of world-renowned CLL experts. These trusted individuals work with our medical writers, scientific contributors, and staff to verify that all content is medically accurate, reflects best practices, and conveys the latest evidence-based information.
Syed Ali Abutalib, MD
Co-Director, Hematology and Cellular Therapy Programs
Director, Clinical NMDP and CTCA Apheresis Programs
Cancer Treatment Centers of America, Affiliate of City of Hope
Zion, Illinois
Farrukh T. Awan, MD
Associate Professor of Internal Medicine
Director of Lymphoid Malignancies Program
Harold C. Simmons Comprehensive Cancer Center
University of Texas Southwestern Medical Center
Dallas, Texas
Jacqueline C. Barrientos, MD, MS
Chief of Hematologic Malignancies
Director of Oncological Research
Adjunct Professor of Medicine, Zucker School of Medicine at Hofstra/Northwell
Adjunct Associate Professor, Feinstein Institutes for Medical Research
Mount Sinai Medical Center Comprehensive Cancer Center
Miami Beach, Florida
Danielle M. Brander, MD
Division of Hematologic Malignancies & Cellular Therapy
Duke Cancer Institute
Durham, North Carolina
Jennifer R. Brown, MD, PhD
Worthington and Margaret Collette Professor of Medicine in the Field of Hematologic Oncology, Harvard Medical School
Director, CLL Center
Dana-Farber Cancer Institute
Boston, Massachusetts
John M. Burke, MD
Associate Chair, US Oncology Hematology Research Program
Rocky Mountain Cancer Centers
Aurora, Colorado
John C. Byrd, MD
The Gordon and Helen Hughes Taylor Professor and Chair
Department of Internal Medicine
University of Cincinnati College of Medicine
Cincinnati, Ohio
Bruce D. Cheson, MD, FACP, FAAAS, FASCO
Hematologist/Oncologist
The Center for Cancer and Blood Disorders
Bethesda, Maryland
Catherine C. Coombs, MD
Associate Clinical Professor of Medicine
Chao Family Comprehensive Cancer Center
University of California, Irvine
Irvine, California
Wei Ding, MD, PhD
Associate Professor of Medicine, Consultant, Hematology
Mayo Clinic
Rochester, Minnesota
Ian Flinn, MD, PhD
Director, Lymphoma Research
Sarah Cannon Center for Blood Cancer
Nashville, Tennessee
Richard R. Furman, MD
Director of the CLL Research Center
Division of Hematology/Oncology
Weill Cornell Medical College
New York, New York
Carmen N. Janes, PharmD, BCOP
Clinical Pharmacy Specialist, Ambulatory Hematologic Malignancies
Department of Pharmacy
The Johns Hopkins Hospital
Baltimore, Maryland
Neil Kay, MD
Consultant, Division of Hematology
Mayo Clinic
Rochester, Minnesota
Thomas Kipps, MD, PhD
Professor of Medicine
Division of Hematology-Oncology
Deputy Director of Research
University of California, San Diego Moores Cancer Center
La Jolla, California
Adam Kittai, MD
Assistant Professor
Division of Hematology
The Ohio State University
Columbus, Ohio
Jean Louise Koff, MD, MSc
Assistant Professor, Department of Hematology and Medical Oncology
Winship Cancer Institute of Emory University
Atlanta, Georgia
Lori Leslie, MD
Director, Indolent Lymphoma and Chronic Lymphocytic Leukemia Programs
Assistant Professor of Medicine, Hackensack Meridian School of Medicine
John Theurer Cancer Center
Hackensack, New Jersey
S. Shahzad Mustafa, MD
Lead Physician – Allergy, Immunology, & Rheumatology
Rochester Regional Health
Clinical Associate Professor of Medicine
University of Rochester School of Medicine and Dentistry
Rochester, New York
Chadi Nabhan, MD, MBA, FACP
Chairman – Precision Oncology Alliance
Caris Life Sciences
Chicago, Illinois
Krish Patel, MD
Director, Lymphoma Program
Interim Chief of Hematologic Malignancies and Cellular Therapies, Swedish Cancer Institute
Seattle, Washington
Tycel J. Phillips, MD
Associate Clinical Professor of Medicine
Department of Hematology & Hematopoietic Cell Transplantation
City of Hope Comprehensive Cancer Center
Duarte, California
Lindsey Roeker, MD
Medical Oncology/Hematology Fellow
Memorial Sloan Kettering Cancer Center
New York, New York
Steven T. Rosen, MD, FACP
Provost and Chief Scientific Officer
Director, Comprehensive Cancer Center and Beckman Research Institute
City of Hope Comprehensive Cancer Center
Duarte, California
Mazyar Shadman, MD, MPH
Associate Professor, Division of Medical Oncology
University of Washington School of Medical Oncology
Associate Professor, Clinical Research Division, Fred Hutchinson Cancer Research Center
Seattle, Washington
Sanjay Sharma, MD
Hematologist/Oncologist
St. Jude Medical Center
Fullerton, California
Tanya Siddiqi, MD
Director, Chronic Lymphocytic Leukemia Program, Toni Stephenson Lymphoma Center
Associate Clinical Professor, Department of Hematology & Hematopoietic Cell Transplantation, City of Hope Comprehensive Cancer Center
Duarte, California
William G. Wierda, MD, PhD
Clinical Medical Director-Department of Leukemia, Division of Cancer Medicine
Professor, Department of Leukemia, Division of Cancer Medicine
Executive Medical Director, Inpatient Medical Services
The University of Texas MD Anderson Cancer Center
Houston, Texas
Adrian Wiestner, MD, PhD
Senior Investigator
Laboratory of Lymphoid Malignancies
National Heart, Lung, and Blood Institute (NHLBI)
National Institutes of Health (NIH)
Bethesda, Maryland
Heather Wolfe, MD
Assistant Professor of Medicine
Director of CLL Survivorship Program
Harold C. Simmons Comprehensive Cancer Center
University of Texas Southwestern Medical Center
Dallas, Texas
Jennifer Woyach, MD
D Warren Brown Professor of Leukemia Research
Section Head, CLL and Hairy Cell Leukemia
Associate Division Director for Clinical Research
Division of Hematology
Co-Director, Leukemia Research Program
Ohio State University Comprehensive Cancer Center
Columbus, Ohio
Laura J. Zitella, MS, RN, ACNP-BC, AOCN
Nurse Practitioner
Hematology, Blood & Marrow Transplant, and Cellular Therapies (HBC) Program
UCSF Helen Diller Family Comprehensive Cancer Center
Associate Clinical Professor, School of Nursing
University of California San Francisco
San Francisco, California
RECENT NEWS
When appropriate, CLL Society will post updates and background information on the present Coronavirus pandemic focusing on reliable primary sources of information and avoiding most of the news that is not directly from reliable medical experts or government and world health agencies.
